About Anastrozole Tablets IP
Anastrozole Tablets IP is a must-have solution for breast cancer treatment, capitalising on top-notch pharmaceutical innovation. This new release features superior efficacy for hormone receptor-positive breast cancer in postmenopausal women. Each resplendent blister pack contains 10 film-coated, easy-to-swallow tablets, meticulously crafted for optimal oral administration. With Anastrozole IP 1 mg as the active ingredient, supported by excipients, it boasts a shelf life of 24 to 36 months. This prescription-only product, distributed across India, reflects excellence in quality and reliability for healthcare professionals.
Exceptional Features and Medical Application
Anastrozole Tablets IP stands out for its special film-coated formulation, ensuring ease of use and enhanced patient compliance. Designed as a pharmaceutical solution, it targets hormone therapy for breast cancer, particularly in postmenopausal women with hormone receptor-positive tumors. Its superior performance, odorless nature, and white to off-white presentation make it a top-choice for both healthcare facilities and oncology practices. The product's practical application in advanced healthcare plants guarantees effective treatment.
Sample Availability, Stock Outlay, and Packaging
With attractive sale prices and immediate stock ready for distribution, Anastrozole Tablets IP supports seamless pharmaceutical operations. Samples are available for evaluation, catering to supplier, distributor, and trader requirements. The packaging features robust blister packs, each containing 1 x 10 tablets, ensuring product stability during transport. The supply ability remains consistent, enabling bulk or tailored outlay to meet ongoing healthcare demands and maximize service efficiency for buyers within India and for export.
FAQ's of Anastrozole Tablets IP:
Q: How should Anastrozole Tablets IP be stored to maintain its superior effectiveness?
A: Anastrozole Tablets IP should be stored below 30C, protected from light and moisture, and kept out of reach of children to preserve its optimal quality and efficacy.
Q: What is the main indication for prescribing Anastrozole Tablets IP?
A: Anastrozole Tablets IP is indicated primarily for the treatment of hormone receptor-positive breast cancer in postmenopausal women, as part of hormone therapy protocols.
Q: When can samples of Anastrozole Tablets IP be requested for evaluation?
A: Samples are readily available for healthcare professionals, distributors, or buyers who wish to evaluate the product before making bulk purchases or distribution arrangements.
Q: Where can Anastrozole Tablets IP be sourced for bulk orders or export?
A: Anastrozole Tablets IP is supplied, distributed, and exported across India, with stock ready for immediate shipment by authorized pharmaceutical traders.
Q: What are the benefits of its film-coated and easy-to-swallow design?
A: The film-coated, easy-to-swallow tablets enhance patient adherence and comfort, reduce gastrointestinal irritation, and improve overall treatment experience and compliance.
Q: How does the packaging outlay contribute to product safety and convenience?
A: Blister pack packaging ensures each set of tablets remains sealed, hygienic, and protected from environmental factors, making distribution and individual dosing safer and more convenient.